The role and efficacy of Axitinib

Axitinib (Axitinib) is a multi-target inhibitor mainly used to treat advanced renal cell carcinoma (RCC). Its function and efficacy are mainly reflected in the following aspects:

1. Targeted inhibition of vascular endothelial growth factor receptor (VEGFR)

Axitinib exerts its effects by inhibiting the vascular endothelial growth factor receptor (VEGFR). VEGFR is a key receptor involved in neovascularization, which is required for tumor growth and spread. By blocking the VEGFR signaling pathway, axitinib can slow down the growth of tumors and inhibit the formation of new blood vessels in tumors, thus blocking the blood supply to tumors.

2. Reduce tumor blood supply

Tumor growth requires a large supply of nutrients and oxygen, which are primarily transported through the blood. The inhibitory effect of axitinib can reduce the density and function of tumor blood vessels and reduce dependence on blood, thereby limiting the tumor's nutrient and oxygen supply. This mechanism helps inhibit tumor progression.

3. Delay the growth and spread of tumors

The action of axitinib helps slow the growth and spread of tumors. By interfering with the growth signaling pathways of tumor cells, inhibiting new blood vessel formation, and reducing tumor blood supply, axitinib can effectively slow down the activity of tumor cells and prolong the progression of the disease.

4. Improve survival rate

Clinical studies have confirmed that axitinib can significantly improve survival rates in patients with advanced renal cell carcinoma. For patients whose disease has progressed after receiving other treatments, the use of axitinib provides an effective treatment option and improves patient prognosis.

5. Improve quality of life

In addition to direct anti-tumor effects, axitinib also helps improve patients' quality of life. By slowing disease progression, alleviating related symptoms, and reducing the need for other treatments, axitinib can help patients better cope with their disease and improve their overall quality of life.

6. Personalized treatment

Because each patient's physiology and tumor characteristics are unique, the use of axitinib often requires an individualized treatment plan. Doctors will adjust drug dosages based on the patient's specific conditions, conduct regular monitoring, and make adjustments based on treatment response and tolerance.

Although axitinib has shown good results in the treatment of advanced renal cell carcinoma, it may also be associated with some side effects, such as hypertension, hand-foot syndrome, fatigue, etc. Therefore, while using axitinib, patients need to pay close attention to their physical condition and report any discomfort to their doctor in a timely manner.

In general, axitinib, as a targeted therapy drug, plays an important role in patients with advanced renal cell carcinoma through multiple mechanisms of action, improving the treatment effect and survival rate, and bringing more treatment options to patients.

Axitinib has been launched in China and has been included in medical insurance. Patients can purchase it domestically. The price of 5mg*28 tablets is about 5,000 to 6,000 yuan. For specific prices, please consult the local hospital pharmacy. There are original and generic axitinib drugs abroad. The original drug is Pfizer's original drug, and the price is about 6,000 yuan; the generic drugs are mainly Bangladeshi generics and Indian generics. The price of Bangladeshi generics in 5mg*60 tablets is more than 1,000 yuan, and the price of Indian generics is around a few hundred yuan. The ingredients of original drugs and generic drugs are basically the same.